Delivery Order SPE2DB22D9225-SPE2DB24FR8EK

Award Date 3/5/24
Potential Completion Date 3/6/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a potential value of $1,440.52 and a completion date of February 6, 2024. This award is part of a larger indefinite delivery contract, 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025, which enables DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,762.08, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The award has a firm fixed-price pricing type and a completion date of May 2, 2024. This order is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group,...
This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a potential value of $5,762.08 and a completion date of March 4, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a potential value of $6,345.88 and a completion date of February 6, 2024. This delivery order is issued against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of 0.5 mL prefilled syringes of the pneumococcal vaccine VAXNEUVANCE. The $13,978.95 delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue orders for a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,440.52 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a potential value of $6,001.89 and a period of performance through March 6, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with the Defense Logistics Agency, valued up to $4,999,999 through 2025, to provide a range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $6,882.30 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA, contract 4600082013 under the SPE2DB program, valued up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $7,202.60 order is for VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA, contract SPE2DB valued up to $4,999,999 through 2025, enabling DLA to place delivery orders for a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $8,643.12 firm fixed-price contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.S0ML, with a completion date of February 22, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which enables DLA to...
  • SPE2DB22D9225
    Indefinite Delivery Contract
  • SPE2DB22D9225-SPE2DB24FR8EK
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.0.5 ML, with a completion date of March 6, 2024 and a potential value of $4,321.56. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. This single-award vehicle enables DLA to issue firm fixed-price delivery orders against the contract for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. The contract has no set-aside designation.

Generated 6/4/24, 10:03 AM